Navigation Links
AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer
Date:3/24/2009

2009 Artery Explorer Tour Kicks Off This Month, Urging People Across the Country to Take Action Against Atherosclerosis

WILMINGTON, Del., March 24 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced the launch of the 2009 US AGAINST ATHERO tour featuring the Artery Explorer -- a state-of-the-art, multisensory, motion simulator that helps people visualize atherosclerosis (athero), the progressive buildup of plaque inside the arteries. The Artery Explorer kicks off its nationwide tour on March 27 in Washington, D.C. and will travel to a total of 16 cities across the country.

US AGAINST ATHERO was conceived three years ago by AstraZeneca after a nationwide Harris Interactive survey confirmed the general public's low level of awareness about athero and its risks. "Working with partners including the Association of Black Cardiologists, the National Alliance on Hispanic Health and WomenHeart, AstraZeneca realized that to get people to take steps to protect their arteries, they needed to see what they could not feel. This fundamental idea led to the creation of US AGAINST ATHERO, a national movement designed to increase awareness of the leading cause of stroke and heart disease, and help Americans fight athero with knowledge.

"The US AGAINST ATHERO movement has made great strides in mobilizing Americans to make healthy choices. However, there is still a lot of work to be done," said Dr. George Kondos, professor of medicine and chief of clinical cardiology at the University of Illinois at Chicago Medical Center. "Athero is a leading cause of heart disease, which remains the number one killer in this country. With the Artery Explorer tour, more people will get the opportunity to really see what happens when you allow the build-up of plaque to progress, and more importantly, what they can do to h
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioDuro and AstraZeneca Expand Collaboration to Optimize Discovery Research for Respiratory and Inflammation Indications
2. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
3. AstraZeneca Implements Customized Cytel East(R) Software for More Accurate Trial Monitoring and Clinical Data Analysis
4. AstraZeneca Appoints Graham Baker Vice President and Chief Financial Officer for North America
5. AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine
6. AstraZeneca and M. D. Anderson Renew Cancer Research Collaboration
7. FDA Approves AstraZenecas SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
8. Melior Enters Research Collaboration with AstraZeneca
9. Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
10. AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Companys Prescription Savings Programs
11. Weitz & Luxenberg Files Seroquel Diabetes Lawsuit Against AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Four-dimensional (4-D) printing develops materials that ... stimuli such as changes in temperature. This advanced ... in multiple industries.  In the near future, 4-D ... objects ranging from human organs to parts used ... Logo - http://photos.prnewswire.com/prnh/20140820/138289 ...
(Date:8/21/2014)... Wednesday of last week RENU 28, the world's first and ... for purchase in Australia and New Zealand, and the response ... is, if you think about the definition of aging, it's ... within your body. If you think about the definition of ... What RENU 28 does is it works with these tiny ...
(Date:8/20/2014)... Aug. 20, 2014 Neurotrope, Inc. (OTCQB: ... conference call to provide an update on Company ... daylight timeDial-in numbers:(888) 505-4369 (U.S. and Canada) or ... cast: www.neurotropebioscience.com , under "Investor Relations"The teleconference replay ... through September 2, 2014 at (888) 203-1112 (U.S. ...
(Date:8/20/2014)... August 20, 2014 Not long ago, ... studies should be performed late in the development cycle ... But current regulatory trends suggest that, like many things ... rise. In recent years, multiple drug sponsors have been ... address specific questions during phase I/II. It’s not only ...
Breaking Biology Technology:Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 3Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 4RENU 28 Skin Care Now Available in Australia and New Zealand 2Neurotrope To Host Conference Call 2Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2
... LA JOLLA, Calif., Jan. 13 Burnham ... an assay development and license agreement with ... L.L.C. (J&JPRD). The agreement is Burnham,s ... company.Under this multi-year agreement, Burnham will provide ...
... - GeneNews Limited (TSX: GEN), a company focused ... detection of diseases and personalized health management, today ... 7,473,528 entitled "Method for the detection of Chagas ... protects the Company,s discovery of a blood biomarker-based ...
... Datafarm, Inc. a leading provider of Electronic Document Publishing Solutions and ... announce the appointment of Mr. Daniel F. Orfe to Vice President, ... will oversee Datafarm,s Regulatory Services Group. , ... Marlborough, ...
Cached Biology Technology:Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2GeneNews granted U.S. patent for Chagas disease based on Sentinel Principle(TM) platform 2Datafarm, Inc., Announces the Appointment of Daniel F. Orfe to Vice President, Global Regulatory Submission Services 2Datafarm, Inc., Announces the Appointment of Daniel F. Orfe to Vice President, Global Regulatory Submission Services 3Datafarm, Inc., Announces the Appointment of Daniel F. Orfe to Vice President, Global Regulatory Submission Services 4
(Date:8/21/2014)... tube connectors, designed by an international standards process, will ... According to an invited review published in the OnlineFirst ... NCP ), the official journal of the American Society ... will greatly reduce the occurrence of misconnection that can ... connectors, which are used to join medical devices, components, ...
(Date:8/21/2014)... from North Carolina State University have developed a novel ... model has applications for creating new materials as well ... "Our new technique allows us to model much larger ... much more quickly," says Nan Li, lead author of ... in NC State,s Department of Materials Science and Engineering. ...
(Date:8/20/2014)... a study of 158 pregnant teenagers in Rochester, NY, ... intentional consumption of ice, cornstarch, vacuum dust, baby powder ... Cornell study. , Moreover, such teens had significantly lower ... eat nonfood substances. , Pregnant teens, regardless of pica, ... lead to iron deficiency and anemia. Low iron in ...
Breaking Biology News(10 mins):New feeding tube connectors will improve patient safety 2Researchers develop models to study polyelectrolytes, including DNA and RNA 2Pica in pregnant teens linked to low iron 2
... WASHINGTON, D.C. (March 7, 2011) -- All our daily activities, ... on signals carried along the body,s vast network of neurons. ... small molecules within nerve cells -- receptors, ion channels, and ... recently, the study of these molecules in real time has ...
... gene that causes Hajdu-Cheney syndrome, a disorder of the ... The study, published in Nature Genetics today, ... highlights the gene as a potential target for treating ... reported cases of Hajdu-Cheney syndrome (HCS), of which severe ...
... separates from Greenland, is the calving due to typical ... called the Scalable, Efficient, and Accurate Community Ice Sheet ... Ridge National Laboratory, aims to use state-of-the-art simulation to ... climate. ORNL computational Earth scientist Kate Evans leads ...
Cached Biology News:Gene responsible for severe osteoporosis disorder discovered 2
... Rabbit Reticulocyte Lysate contains the cellular components ... acids, initiation, elongation and termination factors) but ... Untreated Lysate is used primarily for the ... abundant source of endogenous globin mRNA. Untreated ...
... All MagCellect Ferrofluid products perform ... with R&D Systems MagCellect Magnet. ... this neodymium iron boron permanent ... x 75 mm test tubes ...
... The ScriptCap™ 2'-O-Methyltransferase converts Cap 0 (or ... The Cap 1 structure has been shown ... up to 50%. This improvement is seen ... ScriptCap™ m7G Capping System as well as ...
Request Info...
Biology Products: